Angelo terapija - Company finances
|
EUR
|
2023
From: 2023-11-15
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 721 | 9,687 | 41,334 |
| Profit before tax | 259 | 2,667 | 3,801 |
| Net profit | 259 | 2,533 | 3,586 |
| Equity | 259 | 2,792 | 6,378 |
| Liabilities | 100 | 497 | 490 |
| Non-current assets | 0 | 0 | 1,301 |
| Current assets | 359 | 3,289 | 5,567 |
| Total assets | 359 | 3,289 | 6,868 |
|
Taxes paid
|
|||
| STI taxes | - | - | 1,369 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +1243.6% | +326.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 72.1% | 77.0% | 52.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 90.7% | 56.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 35.9% | 26.1% | 8.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 35.9% | 27.5% | 9.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Angelo terapija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-04-01 | 2026-04-30 | 80.48 |
| 2025-12-02 | 2025-12-31 | 72.45 |
| 2025-08-01 | 2025-08-31 | 72.45 |
| 2025-02-01 | 2025-02-28 | 72.45 |
| 2024-11-04 | 2024-11-30 | 64.50 |
Angelo terapija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-11 | 2026-05-11 | 15.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Angelo terapija, MB (company code 306627767) is a Lithuanian small partnership engaged in retail sale of cosmetic and toilet articles. In the latest financial year, 2025, the company generated revenue of €41.3K and net profit of €3.6K, with a profit margin of 8.7%. Revenue rose strongly from €9.7K in 2024 and €721 in the 2023 short period, showing rapid business expansion across the last three reporting years. Profit also increased from €259 in 2023 to €2.5K in 2024 and €3.6K in 2025, although profitability narrowed relative to sales as turnover expanded. At the end of 2025, total assets stood at €6.9K, including €1.3K in long-term assets and €5.6K in short-term assets. Equity was €6.4K and liabilities €490, indicating a very strong capital structure and limited leverage. Key ratios for 2025 were supported by efficient asset use, with asset turnover at 6.02x, return on equity at 56.2% and return on assets at 52.2%.